Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System
Public ClinicalTrials.gov record NCT03959423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects.
Study identification
- NCT ID
- NCT03959423
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 288 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 24, 2019 (Actual)
- Primary completion
- Mar 17, 2021 (Actual)
- Completion
- Oct 27, 2023 (Actual)
- Last update posted
- Jan 14, 2025
2019 – 2023
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Diabetes and Endocrinology Center | Little Rock | Arkansas | 72211 | — |
| Scripps Whittier Diabetes Institute | La Jolla | California | 92037 | — |
| SoCal Diabetes | Torrance | California | 90505 | — |
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Barbara Davis Center - Adults | Aurora | Colorado | 80045 | — |
| Barbara Davis Center - Pediatric | Aurora | Colorado | 80045 | — |
| Yale Diabetes Research Program | New Haven | Connecticut | 06511 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| Atlanta Diabetes Associates | Atlanta | Georgia | 30318 | — |
| Southeastern Endocrine | Roswell | Georgia | 30076 | — |
| Rocky Mountain Diabetes Center | Idaho Falls | Idaho | 83404 | — |
| International Diabetes Center | Minneapolis | Minnesota | 55416 | — |
| AM Diabetes & Endocrinology Center | Bartlett | Tennessee | 38133 | — |
| Texas Endocrinology | Austin | Texas | 78681 | — |
| Diabetes and Glandular Disease Clinic | San Antonio | Texas | 78229 | — |
| Rainier Clinical Research | Renton | Washington | 98057 | — |
| Seattle Children's Hospital and Medical Center | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03959423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2025 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03959423 live on ClinicalTrials.gov.